APP下载

右美托咪定与咪达唑仑在插管镇静中的应用对比观察

2016-01-20王琳徐艳

中国继续医学教育 2015年25期

王琳 徐艳

右美托咪定与咪达唑仑在插管镇静中的应用对比观察

王琳徐艳

【摘要】目的对比右美托咪定与咪达唑仑在插管镇静中的应用效果。方法 以2014年1月~2014年12月期间80例行全麻经鼻气管插管的患者作为本组的研究对象,按照用药方案将其分为对照组与观察组各40例,对照组给予静脉输注咪达唑仑0.1 μg/kg;观察组给予静脉输注右美托咪定0.6 μg/kg,对比两组患者的插管时间、平均动脉压(MAP)与心率(HR)。结果 两组插管时间之间比较无明显差异,不具有统计学意义,P>0.05。插管前,两组在MAP与HR之间无明显差异。插管后,观察组的MAP与HR均低于对照组,具有统计学意义,P<0.05。结论 在插管镇静中应用右美托咪啶,可以有效稳定患者插管时的血压与心率,其应用效果优于咪达唑仑。

【关键词】右美托咪定;咪达唑仑;插管

作者单位: 276800 山东省日照市东港区人民医院

To Observe the Application of Dexmedetomidine Compared With Midazolam on Sedation During Intubation

WANG Lin XU Yan, the People's Hospital of Donggang District, Rizhao 276800, China

[Abstract]Objective Comparison of dexmedetomidine set with midazolam in intubation sedation application effect. Methods During January 2014 to December 2014, 80 patients undergoing general anesthesia by nasal tracheal intubation as the research object of this group, according to the regimen will the into control group and observation group, each 40 cases, control group was given intravenous infusion of midazolam 0.1 μg/kg midazolam; observation group intravenous infusion of dexmedetomidine 0.6 μg/kg, compared two groups of patients with the intubation time, MAP and HR were measured. Results The intubation time of the observation group and the control group had no significant difference before, not statistically significant, P>0.05. After intubation, the HR and MAP of the observation group were significantly lower than those of the control group, with statistical significance, P<0.05. Conclusion In the intubation sedation application of dexmedetomidine, stable and effective intubating a patient's blood pressure and heart rate, and its application effect is better than that of the MI of midazolam.

[Key words]Dexmedetomidine, Midazolam, Intubation

气管插管是现阶段临床中最常用的人工或机械通气方法之一,其目的是避免口腔咽喉部的分泌物阻塞气道,维持患者呼吸道顺畅[1]。但是在插管时由于管道对患者交感神经造成持续性刺激,经常出现心率过速、血压不稳等不良反应,不利于插管的进行。因此,在气管插管时给予合适的镇静药物至关重要。本文中将对比右美托咪定与咪达唑仑在插管镇静中的应用效果。

1 资料与方法

1.1临床资料

以我院ICU病房于2014年1月~2014年12月期间80例行全麻经鼻气管插管的患者作为本组的研究对象,按照用药方案将其分为对照组与观察组各40例。对……

登录APP查看全文